chalcone has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ale-Ebrahim, M; Faryabi, K; Karkhaneh, L; Mohammadifar, N; Mortazavi, P; Rahmani, R | 1 |
1 other study(ies) available for chalcone and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Atheroprotective and hepatoprotective effects of trans-chalcone through modification of eNOS/AMPK/KLF-2 pathway and regulation of COX-2, Ang-II, and PDGF mRNA expression in NMRI mice fed HCD.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Chalcone; Cyclooxygenase 2; Diet; Kruppel-Like Transcription Factors; Male; Mice; Nitric Oxide Synthase Type III; Non-alcoholic Fatty Liver Disease; Platelet-Derived Growth Factor; RNA, Messenger; Signal Transduction | 2022 |